Segment Information (Tables)

12 Months Ended

Dec. 31, 2022

Financial data by reportable segment for the years ended December 31, 2022, 2021 and 2020 is as follows:


	Commercial & Specialty Business		Government Business		CarelonRx	Other		Eliminations		Total
Year ended December 31, 2022
Operating revenue - unaffiliated	$	41,674	$	96,810	14,974	$	2,202	$	—	$	155,660
Operating revenue - affiliated	—		—		13,552	11,092		(24,644)		—
Operating gain	2,933		3,297		1,868	354		—		8,452
Depreciation and amortization of property and equipment	—		—		—	784		—		784
Year ended December 31, 2021
Operating revenue - unaffiliated	$	38,809	$	82,919	12,655	$	2,560	$	—	$	136,943
Operating revenue - affiliated	—		—		12,776	7,690		(20,466)		—
Operating gain (loss)	2,753		3,061		1,684	(9)		—		7,489
Depreciation and amortization of property and equipment	—		—		—	668		—		668
Year ended December 31, 2020
Operating revenue - unaffiliated	$	36,699	$	71,572	10,384	$	2,153	$	—	$	120,808
Operating revenue - affiliated	—		—		11,527	3,904		(15,431)		—
Operating gain (loss)	2,681		2,444		1,361	(126)		—		6,360
Depreciation and amortization of property and equipment	—		—		—	638		—		638

Major Product Revenues

The major product revenues for each of the reportable segments for the years ended December 31, 2022, 2021 and 2020 are as follows:


	2022		2021		2020
Commercial & Specialty Business
Managed care products	$	33,927	$	31,564	$	29,815
Managed care services	6,152		5,711		5,296
Dental/Vision products and services	1,434		1,363		1,231
Other	161		171		357
Total Commercial & Specialty Business	41,674		38,809		36,699
Government Business
Managed care products	96,322		82,519		71,188
Managed care services	488		400		384
Total Government Business	96,810		82,919		71,572
CarelonRx
Pharmacy products and services	28,526		25,431		21,911
Other
Integrated health services	12,274		9,645		5,787
Other	1,020		605		270
Total Other Business	13,294		10,250		6,057
Eliminations
Eliminations	(24,644)		(20,466)		(15,431)
Total product revenues	$	155,660	$	136,943	$	120,808

Reconciliation Of Reportable Segment Operating Revenues To The Consolidated Statements Of Income

A reconciliation of reportable segments’ operating revenue to the amounts of total revenues included in our consolidated statements of income for the years ended December 31, 2022, 2021 and 2020 is as follows:


	2022		2021		2020
Reportable segments’ operating revenues	$	155,660	$	136,943	$	120,808
Net investment income	1,485		1,378		877
Net (losses) gains on financial instruments	(550)		318		182
Total revenues	$	156,595	$	138,639	$	121,867

Reconciliation Of Reportable Segment Operating Gain To Income From Continuing Operations Before Income Taxes In The Consolidated Statements Of Income

A reconciliation of reportable segments’ operating gain to income before income tax expense included in our consolidated statements of income for the years ended December 31, 2022, 2021 and 2020 is as follows:


	2022		2021		2020
Income before income tax expense	$	7,769	$	7,925	$	6,238
Net investment income	(1,485)		(1,378)		(877)
Net losses (gains) on financial instruments	550		(318)		(182)
Interest expense	851		798		784
Amortization of other intangible assets	767		441		361
Loss on extinguishment of debt	—		21		36
Reportable segments’ operating gain	$	8,452	$	7,489	$	6,360